Landscapes / Companies
CanSino Biologics Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
1 in Phase 3
Next date
24 Nov 2026soon
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine, Phase 1/2 trial completes
Drugs
8
in active trials · 21 in all
Trials
10 active
34 since 2021
Drugs8
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in China | 24 Nov 2026soonPhase 1/2 trial completes | |||
| Next date | 24 Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Pneumococcal Infections, Streptococcal Infections and 2 more | ||||
| Open drug page | |||||
Batch 1 ofnot checked |
— |
Approved in China | Feb 2029Phase 1 trial completes | ||
| Next date | Feb 2029 · Phase 1 trial completes | ||||
| Also tested for | Epidemic Meningitis, Meningococcal Meningitis and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Diphtheria, Tetanus and Acellular Pertussis | ||||
| Open drug page | |||||
— |
Phase 1/2 | 24 Nov 2026soonPhase 1/2 trial completes | |||
| Next date | 24 Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Streptococcus Pneumoniae Infection | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Poliomyelitis | ||||
| Open drug page | |||||
— |
Phase 1 | Feb 2029Phase 1 trial completes | |||
| Next date | Feb 2029 · Phase 1 trial completes | ||||
| Also tested for | Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Haemophilus Influenzae Type B Infection | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Tuberculosis | ||||
| Open drug page | |||||
About
- No active trial
- 13 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021